For in vitro qualitative detection of SARS-CoV-2 nucleocapsid antigen in nasal (NS) swab specimens directly from individuals who are suspected of COVID-19 by their healthcare provider within the first 5 days after onset of symptoms. This test is only provided for use by clinical laboratories or to healthcare workers for point-of-care testing, not for at-home testing. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, or 2019-nCoV) is an enveloped non-segmented positive-sense RNA virus. It is the cause of coronavirus disease (COVID-19), which is contagious in humans. SARS-CoV-2 has several structural proteins including spike (S), envelope (E), membrane (M), and nucleocapsid (N). The antigen is generally detectable in upper respiratory samples during the acute phase of infection. Positive results indicate the presence of viral antigens, but the clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Positive results do not rule out a bacterial infection or co-infection with other viruses. The agent detected may not be the definite cause of disease. Negative results should be treated as presumptive, which do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions. Negative results should be considered in the context of a patient's recent exposures, history, and the presence of clinical signs and symptoms consistent with COVID-19, and confirmed with a molecular assay, if necessary, for patient management. For in vitro diagnostic use only. For professional use only .
1. Nasopharynx swab specimen, non-invasive 2. Very simple to use 3. Convenient, no devices required 4. Rapid, results within 20 minutes 5. Cost-efficient 6:Listed on German BfArm ,got approval by PEI Clinical report from local CDC Sensitivity is 97.14%, Specificity is 100%, total accuracy rate is 99.68%.
The product is based on the principle of antigen-antibody reaction and immunoassay technique. The test device contains colloidal gold labeled SARS-CoV-2 recombinant protein, mouse-anti human IgG antibody immobilized in G test area, mouse-anti human IgM antibody immobilized in M test area and the corresponding antibody in quality control area (C). During the test, when the SARS-CoV-2 IgM antibody level in the sample is at or above the limit of detection of the test, the SARS-CoV-2 IgM antibody in the sample binds to the colloidal gold labeled SARS-CoV-2 recombinant protein which is pre-coated on a gold label pad. The conjugates migrate upward through capillary effect and would be captured by mouse-anti human IgM antibody immobilized in M test area subsequently and this produces a purple-red band appears in the M test area. When the SARS-CoV-2 IgG antibody level in the sample is at or above the limit of detection of the test, the SARS-CoV-2 IgG antibody in the sample binds to the colloidal gold labeled SARS-CoV-2 recombinant protein which is pre-coated on a gold label pad. Theconjugates migrate upward through capillary effect and would be captured by mouse-anti human IgG antibody immobilized in G test area subsequently and this produces a purple-red band appears in the G test area. If it is a negative sample, there is not a purple-red band appeared in the M and G test area. Regardless of the presence or absence of the SARS-CoV-2 antibody in the sample, a purple-red band will appear in the quality control area (C). The purple-red band in the quality control area (C) is a criterion for judging whether there is enough sample and whether the chromatography process is normal. It also serves as the internal control standard for reagents.
We can supply the following brand for covid-19 test kits Flowflex ART kits self-testing Boson Test Kits CAS-ENVISION Self test kit MOQ 100,000 kits
COVID-19 Antigen Rapid Test (Self-Test at Home) Immediate stock : 78,000 test kits OTG Price : USD13.80 per box (2 test kits per box)
Angiten-COVID-19 Virus Test Kit (Colloidal Gold) Quantity of box: 25 persons/box Brand: Easysweet NMPA (National Medical Products Administration): Approved CE: with CE mark BfArM: listed Test Method: Antigen Test Result Time: 10-15 mins Sample Type: Nasal Swab Sensitivity: 96.70% Specificity: 100% Accuracy: 98.94% Shelf Life: 24 months Storage Temperature: 2-30 Degree Celsius Country of Origin: Made in China Additional Information: Production Capacity: 1 million Delivery Time: 10-15 days Packaging Details: 25 tests in a pack, 40packs/ carton Angiten-COVID-19 Virus Test Kit is an in vitro diagnostic rapid test for the qualitative detection of SARS-CoV-2 antigen (Ag) in human nasopharyngeal swab specimens from individuals who meet COVID-19clinical and / or epidemiological criteria. It can be used by professional only.
1) Zhenrui (Immediate Stock) at HKD65 per test 2) Newgene (available in 3-5 days upon order) at HKD30 per test 3) Aripa (available on 22 Feb 2022) at HKD68 per test 4) Healgen (available in 1-2 weeks) at HKD48 per test 5) Giant King (available in 1-2 weeks) at HKD48 per test 6) BioTeke (immediate available - 1M) at HKD30 per test 7) TBG (MOQ : 1M) at USD4.50 per test
Antigen Detection Rapid Lateral Flow Test (latex bead-based) AIVD Biotech's Ag test is a lateral flow immunoassay intended for the qualitative detection of nucleocapsid protein (NP) antigen in direct nasal swabs from individuals suspected of infection. Description: This kit utilizes the principle of latex bead immunochromatography to qualitatively detect the Np antigen in human nasal swabs. Lateral flow immunochromatographic assay provides an easy workflow, short turnaround time, and rapid diagnosis of suspected patients. The test contains latex bead conjugate pad and a membrane strip pre-coated with antibodies specific to the antigen on the test lines (T). If novel NP antigen is present in the specimen, a visible band appears on the test lines (T) as antibody-antigen-antibody latex bead complex forms. The control line (C) is used for procedural control and should always appear if the test is performed correctly. This method does not require expensive medical instruments and consumables. Just take the specimen and add it to the sample well. If sample contains the antigen, it will interact with the latex bead-labeled anti- NP antibodies on the conjugate pad. Required components 1. A foil pouch with a desiccant and a single use test card, 1 piece 3. Sterile swab, 1 piece 3. Extraction buffer tube (1 ml), 1 tube. 4. Instructions for use, 1 piece. Storage conditions 1. Store at the dark place, room temperature 18~28C with low humidity. 2. After opening the foil bag, please use the test cassette within 30 mins. 3. Expiration period 12 month Specimen requirements: 1. Nasopharyngeal swab specimen. 2.Specimen should be tested as soon as possible upon collection. If the sample has to be stored, store the swab sample at room temperature for up to 1 hour or 2~8C for up to 4 hours prior to testing. Performance Characteristics A total of 365 samples from suspected patients were tested by the RT-qPCR test. Testing results are shown in the following table: PCR AIVD Antigen Rapid Test Kit Positive Negative Positive 59 8 Negative 6 292 Total: 65 300 Sensitivity: 90.7%; Specificity: 97.3%.
500k Landed in NY weekly. Connected to second largest Sienna distributor in North America. Carton Pricing starts at $4.50. Message for Pallet and up pricing. PO-POL-Invoice-Wire-Ship/Pick Up
Our products are directly from factories, Boson, H-Guard, Flow flex, etc.
Products we have access to for the US Market OTC: iHealth 2 pack - 4-7 business days from payment AccessBio 2 pack - Available within 3-5 business days FlowFlex 1 Pack- Available for delivery after the 7th Feb Roch 5 Pack- 5 day lead time from payment SD-Biosensor 1 or 2 pack: 100,000 available daily CIF/DDP from South Korea On/Go: Weekly allocation is available on-going, Made in USA! POC: Sienna Celltrion Indicaid GenBody Spring Health OTG: ICPO x Invoice x Inspect and Pay products are available for spot purchases, at a premium price. OTG or OTW: Wire and Ship products are sold with CHAIN OF CUSTODY, AWB, BOL or other proof of Allocation... at slightly better rates. Production opportunities, on-going Allocation, or larger volumes are sold at the best price, with tiered pricing for longer duration contracts. There are financing opportunities available: Factoring ICPO x CounterSigned Invoice for Gov POs, Hospital Organizations, and Fortune 500 Companies. Everyone else must Fund Escrow, or Block Funds, with explicit verbiage guaranteeing the release once the order reaches America, clears customs, and is available for physical inspection/ delivery to the clients destination.
iHealth Tiered Pricing - PrePay or Financed 1M MOQ, 10M & >20M Aggregate Option 1- PRE-Pay & Ship PO x Invoice x Wire 100% x Ship DDP [Better Price, Money Up-front] $14, $13, $12 [.25 comms included] Option 2- Blue Chip Financed Deal ICPO x Invoice w/ POF x Countersign Invoice w/ Commitment to Release Upon Delivery [Requires Strong Buyer KYC] Option 3- Funded Escrow ICPO x Invoice x Fund Escrow/ Block Funds x Inspect & Release [Creates Security - Inspect & Pay] PO details: Ruben L Hudson Advanced Healthcare Resources LLC c/o STM Bio - Goldmanifestor Financed options - Total contract value - 1M would be 14.50 base 10M would 13.50 base 20M+ would be 12.50 base [.25 comms included]
Antigen tests are used in the diagnosis of respiratory pathogens and are immunoassays that detect the presence of a specific viral antigen, which implies current viral infection. COVID-19 Antigen Rapid Test is designed to detect the presence of viral proteins (antigens) expressed by the COVID-19 virus in a sample from the respiratory tract of a person and is gives results in a few minutes whether someone is infectious. Approved by clinical specimens and authorities, this product is intended exclusively for professional use in the laboratory and at the point-of-care. .
Our Panodyne Sars-CoV-2 Antigen rapid swab test kits offers a quick and efficient solution for the early detection of COVID-19 infection within both symptomatic and asymptomatic individuals. Uses a specially designed swab to take samples from either the nasal cavity or tonsils to reveal if a person is infected or not. Suitable for mass testing and for screening workforce in business settings.
Helicobacter pylori is a parasitic bacterium in the stomach that lives between the gastric mucosa and mucus. According to the WHO, more than half of the world's population has H. pylori and is the third leading cause of cancer-related deaths. In 1994, the WHO's IARC classified H. Pylori as a Class 1 carcinogen. The incidence of H. pylori in developing countries is the highest worldwide, highlighting the need for highly accurate and manageable testing. By 2025, the H. pylori testing market is expected to be worth 6 billion. Accordingly, SML Genetree has developed a reagent that can diagnose Helico-bacter pylori and Clarithromycin-resistant mutants (A2142G, A2143G) through DNA extracted from human hygienic tissue using Real-time Polymerase Chain Reaction. Since it contains multiple gene regions, Helico-bacter pylori and Clarithromycin-resistant mutations can be detected sensitively, and high reproducibility has been demonstrated through repeated tests by serially diluting various positive samples and standards. In addition, as a result of clinical evaluation on human sanitary inspection tissue by commissioning a large domestic consignment inspection institution, high sensitivity and specificity were confirmed, proving its excellent clinical performance.
I am representing SD Biosensor from South Korea that manufactures US FDA EUA approved Standard M nCo V Real-Time Detection Kit (COVID Testing kit). We have received US FDA EUA approval to export Covid 19 detection kit in April and can directly export from Korea. SD Biosensor is one of the few companies that has received US FDA approvals and have already sold 1.5 million testing units to US government (Based on US government reaching out to South Korea Government for help with procuring Covid Testing kits). I'm currently in Seoul, South Korea but I'm a US citizen helping SD Biosensor as an agent to help buyers procure these testing kits. This company has capability to manufacture over 600,000 testing units a day and have enough supplies readily available for an immediate export. Please email me at Jinsoo.park@yahoo.com to receive US FDA EUA Approval and product information. rapid test kits which are not FDA approved are in the low to mid $20 range and the price for FDA EUA approved standard test kits are around high $20s to low $30s and depending on the contract length and quantity we have some room for negotiation. Also these kits have to be refrigerated shipped so there will be some additional cost for this.
Sensitivity: 95.06% Specificity: 99.62% Content of each kit: Test card (innovative and unique system), detailed instructions for use, sterile disposable swab, reactive solution for sample treatment, illustrative manual for use and operation. General characteristics: CE self-diagnostic certification, holographic security label with individual code for authenticity verification, non-invasive, easy to use, no prescription required, rapid results in less than 15 minutes, high precision. Sale restrictions: Exclusive sale to pharmacies, authorized companies, pharmaceutical distribution, socio-sanitary establishments, health establishments, occupational risk prevention, public organizations and health professionals. Restricted sale to individuals. Sale subject to the provisions of Royal Decree 588/2021, of July 20, which modifies Royal Decree 1662/2000, of September 29, on medical devices for "in vitro" diagnosis, in order to regulate the sale to the public and the advertising of covid-19 self-diagnosis products. Sale subject in relation to tax matters to the provisions of Royal Legislative Decree 35/2020, of December 22, seventh final provision. Applicable tax rate of Value Added Tax to deliveries, imports and intra-community acquisitions of certain goods and provision of services necessary to combat the effects of SARS-CoV-2 as well as for the purposes of the special regime of the equivalence surcharge .
This kit is used to detect RBV antigen in saliva secretion of dogs and cats, and can be used for screening of RBV infection and auxiliary diagnosis. test time: 10- 15min Package specification:20 tests/kit
This kit is using detecting canine parvovirus antigen in canine feces, rectum, vomitus, or saliva. It can be used for screening canine parvovirus infection ,auxiliary diagnosis and so on. Test time:5-10min
The kit uses colloidal gold immunochromatography assay (GICA) to detected antibodies against Brucella in cattle, sheep and goats. The test duration is 10-15 minutes. 20tests/kit